Anavex Life Sciences Overview

Anavex Life Sciences Research & Development

Research & Development expenses for AVXL.

Quarterly R&D Expenses

$4.66M

↓ 55.43% YoY

As of Dec 31, 2025

Annual R&D Expenses (TTM)

$31.80M

↓ 27.06% YoY

Trailing 12 months ending Dec 31, 2025

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin